Therapeutic role and potential mechanisms of active Vitamin D in renal interstitial fibrosis
- 31 March 2007
- journal article
- Published by Elsevier BV in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 103 (3-5), 491-496
- https://doi.org/10.1016/j.jsbmb.2006.11.011
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Renal fibrosis: New insights into the pathogenesis and therapeuticsKidney International, 2006
- Antiproteinuric effect of oral paricalcitol in chronic kidney diseaseKidney International, 2005
- Id family of helix-loop-helix proteins in cancerNature Reviews Cancer, 2005
- A Novel Mechanism by which Hepatocyte Growth Factor Blocks Tubular Epithelial to Mesenchymal TransitionJournal of the American Society of Nephrology, 2005
- Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of actionAmerican Journal of Physiology-Renal Physiology, 2004
- Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressureThe Journal of Steroid Biochemistry and Molecular Biology, 2004
- 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin systemJCI Insight, 2002
- Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signalingThe Journal of cell biology, 2001
- The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expressionNature, 2000
- The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cellsNature, 2000